Yubing Hu

Assistant Professor

Shenzhen University
Country flagChina
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Neuroblastoma diagnosis typically relies on several invasive and time-consuming processes. POC testing provides rapid results, and often does not require specialised equipment or training, meaning that it can be used by patients at home.

Year:

2025

Nanoplastics (NPs) act as carriers of heavy metals and pose toxicity to aquatic organisms due to their affinity for heavy metals; however, the particular role of NPs in this joint toxicity remains unclear.

Year:

2024

Photonic technologies have made enormous impacts on modern medicine, advancing disease diagnostics and treatments as well as health monitoring. A long‐standing challenge in the use of light and its widespread effects in photomedicine is the finite penetration of light in tissues. However, judiciously engineered optical fibers helped overcome this challenge and advance light delivery to deep tissues with spatial precision and desired accessibility. In recent years, the development of photonic technologies including optical biomaterials, fiber functionalization, and biomedical device innovations has greatly expanded the scope of light‐based healthcare. Here, the fundamentals and materials of fiber optics to endow themselves with biocompatibility, flexibility, and diverse functionalities required for long‐term implantation are overviewed. The design strategies of lab‐on‐fiber techniques, operation requirements to construct fiber optic sensors, and their health monitoring applications as wearable and implantable devices are presented. The use of fiber optics in major light‐based therapeutic modalities including optogenetics, photodynamic therapy, photobiomodulation, photochemical cross–linking, and photothermal therapy is illustrated to enhance their effectiveness, specificity, and feasibility. In short, a comprehensive review is provided on the fiber optic techniques and the latest photonic devices, which are envisioned to evolve photomedicine in clinical and point‐of‐care practices.

Year:

2024

Early and accurate diagnosis of glaucoma is crucial to prevent the progressive deterioration that leads to irreversible vision loss. It is imperative to develop an effective screening tool for glaucoma. Ciliary neurotrophic factor (CNTF) is a tear biomarker implicated in glaucoma pathogenesis. Lateral flow assay (LFA) provides an ideal platform for detection of glaucoma in tear fluid. A quantum dot‐based fluorescence LFA, integrated with a 3D printed readout box, is developed for fast (30 min), sensitive, and quantitative CNTF detection in tears. A standard curve is firstly generated for the quantitative detection of CNTF. The limit of detection (LOD) of the obtained LFA strip at 6.45 pg·mL −1 is comparable to that of the enzyme‐linked immunosorbent assay (ELISA) at 6.42 pg·mL −1 . This enables the identification of low CNTF levels (25.7 ± 14.9 pg·mL −1 ) reported in tear fluid from glaucoma patients. This LFA is found to be highly selective for CNTF and maintained consistent results in different pH condition. The strip remaines stablewhen stored in the darkat room temperature. A smartphone app is developed to simplify analysis and enable prompt and easily obtainable results. This method shows great potential to be a powerful tool for point‐of‐care glaucoma screening.

Year:

2024

A safe, accurate, and reliable sensing platform for urinary biomarkers analysis of urinary biomarkers is clinically important for the early detection and monitoring of the progression of chronic kidney disease (CKD), as it has become one of the world's most prevalent non-communicable diseases.

Year:

2024

Point‐of‐care (POC) has the capacity to support low‐cost, accurate and real‐time actionable diagnostic data. Microneedle sensors have received considerable attention as an emerging technique to evolve blood‐based diagnostics owing to their direct and painless access to a rich source of biomarkers from interstitial fluid. This review systematically summarizes the recent innovations in microneedle sensors with a particular focus on their utility in POC diagnostics and personalized medicine. The integration of various sensing techniques, mostly electrochemical and optical sensing, has been established in diverse architectures of “lab‐on‐a‐microneedle” platforms. Microneedle sensors with tailored geometries, mechanical flexibility, and biocompatibility are constructed with a variety of materials and fabrication methods. Microneedles categorized into four types: metals, inorganics, polymers, and hydrogels, have been elaborated with state‐of‐the‐art bioengineering strategies for minimally invasive, continuous, and multiplexed sensing. Microneedle sensors have been employed to detect a wide range of biomarkers from electrolytes, metabolites, polysaccharides, nucleic acids, proteins to drugs. Insightful perspectives are outlined from biofluid, microneedles, biosensors, POC devices, and theragnostic instruments, which depict a bright future of the upcoming personalized and intelligent health management.

Year:

2024

Collaborators (5)

Nan Jiang

Professor

Sichuan University

CHINA
View details

Tung‐Chun Lee

University College London

UNITED KINGDOM
View details

Ali K. Yetisen

Associate Professor

Imperial College London

UNITED KINGDOM
View details

Savas Tasoglu

Max Planck Institute for Intelligent Systems

GERMANY
View details

Dr. Buddha Deka Boruah

Associate Professor

University College London

UNITED KINGDOM
View details